University of California San Francisco

Publications

  1. Early Improvement in Wound, Ischaemia, and foot Infection (WIfI) Ischaemia Grade Lowers Risk of Major Amputation following Revascularisation for Chronic Limb Threatening Ischaemia.
    2026 | PubMed
  2. Clinical profiles of chronic lymphocytic leukaemia patients with SF3B1 mutations: A single-institution study.
    2025 | PubMed
  3. Characteristics of multidisciplinary limb preservation teams and their impact on outcomes in the BEST-CLI trial.
    2025 | PubMed
  4. High Transepidermal Water Loss at the Site of Wound Closure Is Associated With Increased Recurrence of Diabetic Foot Ulcers: The NIDDK Diabetic Foot Consortium TEWL Study.
    2025 | PubMed
  5. Perioperative Events Following Open Versus Endovascular Revascularization for Chronic Limb-Threatening Ischemia: An NSQIP Analysis.
    2025 | PubMed
  6. Inference of the Mass Composition of Cosmic Rays with Energies from 10^{18.5} to 10^{20}  eV Using the Pierre Auger Observatory and Deep Learning.
    2025 | PubMed
  7. A Novel Preoperative Risk Score to Identify Patients at High Risk for Nonhome Discharge after Elective Open Abdominal Aortic Aneurysm Repair.
    2024 | PubMed
  8. Editor's Choice - Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes.
    2024 | PubMed
  9. The "Woundosome" Concept and Its Impact on Procedural Outcomes in Patients With Chronic Limb-Threatening Ischemia.
    2024 | PubMed
  10. Risk factors and associated outcomes of postoperative delirium after open abdominal aortic aneurysm repair.
    2023 | PubMed
  11. Effectiveness of revascularisation for the ulcerated foot in patients with diabetes and peripheral artery disease: A systematic review.
    2023 | PubMed
  12. Case planning and execution of inframalleolar bypass for chronic limb-threatening ischemia.
    2023 | PubMed
  13. Presenting limb severity is associated with long-term outcomes after infrainguinal revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  14. Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.
    2022 | PubMed
  15. Factors associated with lower preoperative quality of life in patients with chronic limb-threatening ischemia in the BEST-CLI trial.
    2022 | PubMed
  16. Patient-Reported Outcome Measures in Symptomatic, Non-Limb-Threatening Peripheral Artery Disease: A State-of-the-Art Review.
    2021 | PubMed
  17. Invasive treatment of claudication: Time for better measures and better controls.
    2021 | PubMed
  18. Evaluation and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens using a new multiplex assay: a real-life experience on an Italian population.
    2021 | PubMed
  19. Consensus-based perioperative protocols during the COVID-19 pandemic.
    2020 | PubMed
  20. Living in a Food Desert is Associated with 30-day Readmission after Revascularization for Chronic Limb-Threatening Ischemia.
    2020 | PubMed
  21. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer.
    2020 | PubMed
  22. Oral Resolvin D1 attenuates early inflammation but not intimal hyperplasia in a rat carotid angioplasty model.
    2019 | PubMed
  23. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2019 | PubMed
  24. Pro-resolving lipid mediators in vascular disease.
    2018 | PubMed
  25. Resolution of vascular injury: Specialized lipid mediators and their evolving therapeutic implications.
    2017 | PubMed
  26. Novel association between bone mineral density scores and the prevalence of peripheral artery disease in both sexes.
    2016 | PubMed
  27. Predictors of major amputation despite patent bypass grafts.
    2016 | PubMed
  28. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease.
    2015 | PubMed
  29. A systematic review for the screening for peripheral arterial disease in asymptomatic patients.
    2015 | PubMed
  30. Routine use of a protease zymogen-based colorimetric assay for the detection of Beta-glucan and its role in clinical practice.
    2014 | PubMed
  31. Factors associated with primary vein graft occlusion in a multicenter trial with mandated ultrasound surveillance.
    2013 | PubMed
  32. Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease.
    2013 | PubMed
  33. Mineralocorticoid receptor antagonism inhibits vein graft remodeling in mice.
    2012 | PubMed
  34. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease.
    2012 | PubMed
  35. Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling.
    2011 | PubMed
  36. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    2010 | PubMed
  37. Multi-contrast high spatial resolution black blood inner volume three-dimensional fast spin echo MR imaging in peripheral vein bypass grafts.
    2010 | PubMed
  38. In vivo human lower extremity saphenous vein bypass grafts manifest flow mediated vasodilation.
    2009 | PubMed
  39. Comparison of costs of staged versus simultaneous lower extremity arterial hybrid procedures.
    2008 | PubMed
  40. Lower extremity vein graft failure: a translational approach.
    2008 | PubMed
  41. Screening for cardiovascular risk factors in a dental setting.
    2007 | PubMed
  42. Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness.
    2006 | PubMed
  43. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype.
    2005 | PubMed
  44. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts.
    2004 | PubMed
  45. Transcription factor decoys for the prevention of vein bypass graft failure.
    2003 | PubMed
  46. Endothelial cell seeding influences lesion development following arterial injury in the cholesterol-fed rabbit.
    2002 | PubMed
  47. Monocyte adhesion to balloon-injured arteries: the influence of endothelial cell seeding.
    2001 | PubMed
  48. Infrainguinal arterial reconstructions with vein grafts in patients with prior aortic procedures: the influence of aneurysm and occlusive disease.
    2000 | PubMed
  49. Effect of renal insufficiency on outcome following infrarenal aortic surgery.
    1997 | PubMed
  50. Preoperative ultrasound assessment of omental spread in ovarian cancer.
    1994 | PubMed
  51. Pseudofolliculitis barbae. No 'pseudoproblem'.
    1979 | PubMed
  52. Instrument and Supply Variability: An Opportunity to Reduce the Carbon Footprint of the Operating Room.
    2023 | PubMed
  53. Long-term Lower Extremity and Cardiovascular Complications after Simultaneous Pancreas-Kidney Transplant.
    2021 | PubMed
  54. UVI5008: the first reversible, non-covalent Bruton's tyrosine kinase epi-inhibitor for B-cell malignancies.
    2026 | PubMed
  55. Atherectomy Is Not Associated With Improved Limb-Based Outcomes Among Patients in the BEST-CLI Trial Undergoing Endovascular Revascularization.
    2026 | PubMed
  56. Editor's Choice - Association Between Anatomical Patterns of Arterial Occlusive Disease and Endovascular Outcomes in the BEST-CLI Trial Supports the Use of the Global Limb Anatomic Staging System.
    2025 | PubMed
  57. Three-Year Recurrence in People With Diabetic Foot Ulcers and Chronic Limb Threatening Ischemia Is Comparable to Cancer.
    2025 | PubMed
  58. A systematic review supporting the Society for Vascular Surgery guideline update on the management of intermittent claudication.
    2025 | PubMed
  59. The Incidence and Consequences of Endovascular Technical Failure in Patients with Chronic Limb-Threatening Ischemia: Results from the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb-Threatening Ischemia (BEST-CLI) Trial.
    2025 | PubMed
  60. Large language models can accurately populate Vascular Quality Initiative procedural databases using narrative operative reports.
    2024 | PubMed
  61. Antithrombotic Strategies for Patients With Peripheral Artery Disease: JACC Scientific Statement.
    2024 | PubMed
  62. The importance of optimal medical therapy in patients undergoing lower extremity bypass.
    2024 | PubMed
  63. Exploring the impact of type II diabetes mellitus on voice quality.
    2024 | PubMed
  64. Decreasing prevalence of centers meeting the Society for Vascular Surgery abdominal aortic aneurysm guidelines in the United States.
    2023 | PubMed
  65. Effectiveness of bedside investigations to diagnose peripheral artery disease among people with diabetes mellitus: A systematic review.
    2023 | PubMed
  66. Lower-extremity pressure, staging, and grading thresholds to identify chronic limb-threatening ischemia.
    2023 | PubMed
  67. Relationship between WIfI stage and quality of life at revascularization in the BEST-CLI trial.
    2022 | PubMed
  68. Association of Intraoperative and Perioperative Transfusions with Postoperative Cardiovascular Events and Mortality After Infrainguinal Revascularization.
    2022 | PubMed
  69. Society for Vascular Surgery appropriate use criteria for management of intermittent claudication.
    2022 | PubMed
  70. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia.
    2021 | PubMed
  71. Understanding value and patient complexity among common inpatient vascular surgery procedures.
    2021 | PubMed
  72. Patients with depression are less likely to go home after critical limb revascularization.
    2020 | PubMed
  73. Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program.
    2020 | PubMed
  74. Clinical Effectiveness and Resource Utilization of Surgery versus Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    2020 | PubMed
  75. Where do We Go to in the Treatment of Acute Limb Ischaemia?
    2020 | PubMed
  76. Building a global alliance in vascular surgery.
    2019 | PubMed
  77. Using the Society for Vascular Surgery Wound, Ischemia, and foot Infection classification to identify patients most likely to benefit from revascularization.
    2019 | PubMed
  78. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2018 | PubMed
  79. Cryopreserved saphenous vein as a last-ditch conduit for limb salvage.
    2017 | PubMed
  80. Design and Rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial.
    2016 | PubMed
  81. The natural history of untreated severe or critical limb ischemia.
    2015 | PubMed
  82. Surgical intervention for peripheral arterial disease.
    2015 | PubMed
  83. Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.
    2015 | PubMed
  84. Clinical correlates of red blood cell omega-3 fatty acid content in male veterans with peripheral arterial disease.
    2014 | PubMed
  85. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI).
    2013 | PubMed
  86. Risk prediction of 30-day readmission after infrainguinal bypass for critical limb ischemia.
    2013 | PubMed
  87. Medical management of peripheral arterial disease: bridging the "gap"?
    2012 | PubMed
  88. Effects of fatty acids on endothelial cells: inflammation and monocyte adhesion.
    2012 | PubMed
  89. Assessing drug elution technologies in the superficial femoral artery.
    2011 | PubMed
  90. Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis.
    2010 | PubMed
  91. Surgical revascularization. Introduction.
    2009 | PubMed
  92. Inferior outcomes of autogenous infrainguinal bypass in Hispanics: an analysis of ethnicity, graft function, and limb salvage.
    2009 | PubMed
  93. Early remodeling of lower extremity vein grafts: inflammation influences biomechanical adaptation.
    2008 | PubMed
  94. Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial.
    2007 | PubMed
  95. Edifoligide: a transcription factor decoy to modulate smooth muscle cell proliferation in vein bypass.
    2007 | PubMed
  96. Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery.
    2006 | PubMed
  97. Sexuality in aging male.
    2005 | PubMed
  98. Primer extension assay for prion protein genotype determination in sheep.
    2004 | PubMed
  99. Transaortic endarterectomy for primary mesenteric revascularization.
    2002 | PubMed
  100. Monocyte adhesion to human vein grafts: a marker for occult intraoperative injury?
    2001 | PubMed
  101. Autogenous composite vein bypass graft for infrainguinal arterial reconstruction.
    2001 | PubMed
  102. Molecular identification of the cross-reacting epitope on alphaM beta2 integrin I domain recognized by anti-alphaIIb beta3 monoclonal antibody 7E3 and its involvement in leukocyte adherence.
    1998 | PubMed
  103. Pulmonary failure following lower torso ischemia: clinical evidence for a remote effect of reperfusion injury.
    1995 | PubMed
  104. Repopulation of injured arteries with genetically modified endothelial cells.
    1992 | PubMed
  105. Attitudes toward Sustainability among Surgeons at Ten Academic Hospitals in the United States: Are we Ready, Willing, and Incentivized to Change?
    2025 | PubMed
  106. Evaluation of a novel platform for placement confirmation of enteral feeding tubes in adults.
    2023 | PubMed
  107. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    2020 | PubMed
  108. Reply to the Letter to the Editor: "Diabetes Increases Residual Stress and Microcrack Length in Dentin: An XRD-SEM Study with AI-assisted Quantification".
    2026 | PubMed
  109. High rates of nonindex limb amputation in the Best Endovascular versus Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial.
    2025 | PubMed
  110. Diabetes Increases Residual Stress and Microcrack Length in Dentin: An XRD-SEM Study with AI-assisted Quantification.
    2025 | PubMed
  111. Validation of Pedal Acceleration Time for the Assessment of Perfusion in Patients with Chronic Limb-Threatening Ischemia.
    2025 | PubMed
  112. Editor's Choice - Bypass After Failed Endovascular Intervention Is Associated with an Increased Risk of Above Ankle Amputation Among Patients with Chronic Limb Threatening Ischaemia in a Randomised Trial Population.
    2025 | PubMed
  113. Institutional toe & flow programs: How and why the teams work.
    2025 | PubMed
  114. The Impact of pH on the Piezoelectric Properties of Dentin in Root Canal Treated Teeth: Implications for Dental Materials and Oral Health.
    2024 | PubMed
  115. The impact of revascularization strategy on clinical failure, hemodynamic failure, and chronic limb-threatening ischemia symptoms in the BEST-CLI Trial.
    2024 | PubMed
  116. Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization.
    2024 | PubMed
  117. Demonstrating Agreement between Radio and Fluorescence Measurements of the Depth of Maximum of Extensive Air Showers at the Pierre Auger Observatory.
    2024 | PubMed
  118. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer.
    2023 | PubMed
  119. Transcatheter Arterialization of Veins in Chronic Limb-Threatening Ischemia.
    2023 | PubMed
  120. Cognitive Impairment is Common in a Veterans Affairs Population with Peripheral Arterial Disease.
    2022 | PubMed
  121. Screening for co-infections in patients with substance use disorders and severe bacterial infections.
    2022 | PubMed
  122. Searching for a New Parameter in the Healing of Tibia Pilon Fractures: Fracture Area Measurement.
    2022 | PubMed
  123. 17R/S-Benzo-RvD1, a synthetic resolvin D1 analogue, attenuates neointimal hyperplasia in a rat model of acute vascular injury.
    2022 | PubMed
  124. Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD Trial.
    2021 | PubMed
  125. A Limb is a Peninsula- and No Clinician is an Island: Introducing the American Limb Preservation Society (ALPS).
    2021 | PubMed
  126. Reply.
    2020 | PubMed
  127. Specialized pro-resolving lipid mediators in cardiovascular disease, diagnosis, and therapy.
    2020 | PubMed
  128. Natural history of acute pediatric iliofemoral artery thrombosis treated with anticoagulation.
    2020 | PubMed
  129. Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.
    2019 | PubMed
  130. A systematic review and meta-analysis of revascularization outcomes of infrainguinal chronic limb-threatening ischemia.
    2019 | PubMed
  131. Resolvin D1 decreases abdominal aortic aneurysm formation by inhibiting NETosis in a mouse model.
    2018 | PubMed
  132. Data, guidelines, and practice of revascularization for claudication.
    2017 | PubMed
  133. Aspirin-triggered resolvin D1 attenuates PDGF-induced vascular smooth muscle cell migration via the cyclic adenosine monophosphate/protein kinase A (cAMP/PKA) pathway.
    2017 | PubMed
  134. Reversible cerebral vasoconstriction syndrome is a rare cause of stroke after carotid endarterectomy.
    2016 | PubMed
  135. Alpine Skiing With total knee ArthroPlasty (ASWAP): impact on molecular and architectural features of musculo-skeletal ageing.
    2015 | PubMed
  136. Primary stenting in femoropopliteal occlusive disease - what is the appropriate role?
    2015 | PubMed
  137. The pro-resolving lipid mediator maresin 1 (MaR1) attenuates inflammatory signaling pathways in vascular smooth muscle and endothelial cells.
    2014 | PubMed
  138. Short-term physical inactivity impairs vascular function.
    2014 | PubMed
  139. Clinical consequence of bare metal stent and stent graft failure in femoropopliteal occlusive disease.
    2013 | PubMed
  140. A single nucleotide polymorphism in the p27(Kip1) gene is associated with primary patency of lower extremity vein bypass grafts.
    2013 | PubMed
  141. Diabetic revascularization: endovascular versus open bypass--do we have the answer?
    2012 | PubMed
  142. Polyunsaturated fatty acids and peripheral artery disease.
    2012 | PubMed
  143. Analysis of variables predictive of severity in biliary peritonitis.
    2010 | PubMed
  144. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    2010 | PubMed
  145. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia.
    2009 | PubMed
  146. Atherosclerotic Peripheral Vascular Disease Symposium II: lower-extremity revascularization: state of the art.
    2008 | PubMed
  147. Buflomedil in peripheral arterial disease: trials and tribulations.
    2008 | PubMed
  148. Molecular engineering of vein bypass grafts.
    2007 | PubMed
  149. Resource utilization in the treatment of critical limb ischemia: The effect of tissue loss, comorbidities, and graft-related events.
    2006 | PubMed
  150. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial.
    2005 | PubMed
  151. Carotid endarterectomy: who is the high-risk patient?
    2004 | PubMed
  152. The impact of patient age and aortic size on the results of aortobifemoral bypass grafting.
    2003 | PubMed
  153. Initial experience with minimally invasive in situ bypass procedure with blind valvulotomy.
    2002 | PubMed
  154. Infrainguinal bypass grafting in patients with end-stage renal disease: improving outcomes?
    2001 | PubMed
  155. Recombinant growth hormone (GH) therapy in GH-deficient adults: a long-term controlled study on daily versus thrice weekly injections.
    2000 | PubMed
  156. The ideal small arterial substitute: a search for the Holy Grail?
    1998 | PubMed
  157. Endothelialization of prosthetic vascular grafts: current status and future directions.
    1995 | PubMed
  158. Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management.
    1990 | PubMed
  159. Needs Assessment for the Development of a Sustainability Curriculum for Surgical Residents.
    2024 | PubMed
  160. The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement.
    2021 | PubMed
  161. Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis.
    2026 | PubMed
  162. Influence of specialty on endovascular practice patterns and outcomes in the BEST-CLI Trial.
    2025 | PubMed
  163. Management of Diabetic Wounds: Expert Panel Consensus Statement.
    2025 | PubMed
  164. Anatomic profile of arterial occlusive disease in the BEST-CLI trial.
    2025 | PubMed
  165. Search for the Anomalous Events Detected by ANITA Using the Pierre Auger Observatory.
    2025 | PubMed
  166. Vascular Quality Initiative assessment of compliance with Society for Vascular Surgery Practice Guidelines for the endovascular management of claudication.
    2025 | PubMed
  167. The impact of diabetes mellitus on the outcomes of revascularization for chronic limb-threatening ischemia in the BEST-CLI trial.
    2024 | PubMed
  168. Infrapopliteal Endovascular Interventions for Claudication Are Associated With Poor Long-term Outcomes in Medicare-matched Registry Patients.
    2024 | PubMed
  169. Relevance of BEST-CLI trial endpoints in a tertiary care limb preservation program.
    2024 | PubMed
  170. Mechanical properties of simulated dentin caries treated with metal cations and L-ascorbic acid 2-phosphate.
    2023 | PubMed
  171. Apples and oranges? A comparison of BEST-CLI to BASIL-2.
    2023 | PubMed
  172. Iliac artery calcification score stratifies mortality risk estimation in patients with chronic limb-threatening ischemia undergoing revascularization.
    2023 | PubMed
  173. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
    2022 | PubMed
  174. Association of Renin-Angiotensin-Aldosterone System Inhibitor Usage Patterns with Midterm Amputation-Free Survival after Lower Extremity Bypass for Peripheral Arterial Disease.
    2022 | PubMed
  175. Limb-based patency as a measure of effective revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  176. Endovascular treatment of high-risk peripheral vascular occlusive lesions: a review of current evidence and emerging applications of intravascular lithotripsy, atherectomy, and paclitaxel-coated devices.
    2021 | PubMed
  177. Precision Medicine Enables More TNM-Like Staging in Patients With Chronic Limb Threatening Ischemia.
    2021 | PubMed
  178. The Global Limb Anatomic Staging System is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia.
    2021 | PubMed
  179. Implementing global chronic limb-threatening ischemia guidelines in clinical practice: Utility of the Society for Vascular Surgery Threatened Limb Classification System (WIfI).
    2020 | PubMed
  180. Corrigendum to "Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischaemia" [Eur J Vasc Endovasc Surg 58 (1S) (2019) 1-109>].
    2020 | PubMed
  181. Antegrade common femoral artery closure device use is associated with decreased complications.
    2020 | PubMed
  182. Validation of randomized controlled trial-derived models for the prediction of postintervention outcomes in chronic limb-threatening ischemia.
    2019 | PubMed
  183. Global vascular guidelines on the management of chronic limb-threatening ischemia.
    2019 | PubMed
  184. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rabbit vein graft model.
    2018 | PubMed
  185. Invited commentary.
    2017 | PubMed
  186. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.
    2016 | PubMed
  187. High prevalence of sIgE to Galactose-α-1,3-galactose in rural pre-Alps area: a cross-sectional study.
    2016 | PubMed
  188. Revascularization for chronic limb-threatening ischaemia.
    2015 | PubMed
  189. A systematic review of treatment of intermittent claudication in the lower extremities.
    2015 | PubMed
  190. Clinical trials in peripheral vascular disease: pipeline and trial designs: an evaluation of the ClinicalTrials.gov database.
    2014 | PubMed
  191. Growing impact of restenosis on the surgical treatment of peripheral arterial disease.
    2013 | PubMed
  192. Proceedings from the Society of Interventional Radiology research consensus panel on critical limb ischemia.
    2013 | PubMed
  193. Thirty-day vein remodeling is predictive of midterm graft patency after lower extremity bypass.
    2012 | PubMed
  194. Sex-based differences in the inflammatory profile of peripheral artery disease and the association with primary patency of lower extremity vein bypass grafts.
    2012 | PubMed
  195. Regarding "results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial".
    2011 | PubMed
  196. Challenges of distal bypass surgery in patients with diabetes: patient selection, techniques, and outcomes.
    2010 | PubMed
  197. Novel adipokines, high molecular weight adiponectin and resistin, are associated with outcomes following lower extremity revascularization with autogenous vein.
    2010 | PubMed
  198. Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials.
    2009 | PubMed
  199. Risk factors for failure of lower-extremity revascularization procedures: are they different for bypass and percutaneous procedures?
    2008 | PubMed
  200. Lower extremity peripheral vein bypass graft wall thickness changes demonstrated at 1 and 6 months after surgery with ultra-high spatial resolution black blood inner volume three-dimensional fast spin echo magnetic resonance imaging.
    2007 | PubMed
  201. Superficial femoral artery percutaneous intervention is an effective strategy to optimize inflow for distal origin bypass grafts.
    2007 | PubMed
  202. Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia.
    2006 | PubMed
  203. Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure.
    2005 | PubMed
  204. Thoracovisceral segment aneurysm repair after previous infrarenal abdominal aortic aneurysm surgery.
    2004 | PubMed
  205. Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
    2002 | PubMed
  206. Usefulness of autogenous bypass grafts originating distal to the groin.
    2002 | PubMed
  207. Arterial reconstruction for lower limb ischemia.
    2001 | PubMed
  208. Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial.
    1999 | PubMed
  209. The impact of gender on the results of arterial bypass with in situ greater saphenous vein.
    1995 | PubMed
  210. [Minor skull trauma in pediatrics].
    1993 | PubMed
  211. [Intraparietal hematomas of the small intestine during anticoagulant treatment].
    1972 | PubMed
  212. Renal Embolization-Induced Uremic Swine Model for Assessment of Next-Generation Implantable Hemodialyzers.
    2023 | PubMed
  213. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    2020 | PubMed
  214. Open versus Endovascular Revascularisation for Femoropopliteal Disease in Patients with Chronic Limb Threatening Ischaemia.
    2026 | PubMed
  215. Energy Spectrum of Ultrahigh-Energy Cosmic Rays across Declinations -90° to +44.8° as Measured at the Pierre Auger Observatory.
    2025 | PubMed
  216. Clinical effectiveness of drug eluting technologies for femoropopliteal disease.
    2025 | PubMed
  217. Towards definitive functional forms for Monin-Obukhov similarity functions in stable and very stable surface layers.
    2025 | PubMed
  218. Society for Vascular Surgery Clinical Practice Guideline on the management of intermittent claudication: Focused update.
    2025 | PubMed
  219. Validation of nonhome discharge risk score after elective infrainguinal bypass surgery.
    2025 | PubMed
  220. Advanced Wound, Ischemia, and Foot Infection stage is associated with poor outcomes in the BEST-CLI trial.
    2024 | PubMed
  221. Dynamic changes in proresolving lipid mediators and their receptors following acute vascular injury in male rats.
    2024 | PubMed
  222. Fixing a Hole: a retrospective cohort study evaluating HAV, HBV, tetanus screening, and vaccination during hospitalization in persons who use substances.
    2024 | PubMed
  223. Predictors of amputation-free survival and wound healing after infrainguinal bypass with alternative conduits.
    2024 | PubMed
  224. Tissue factor targeting peptide enhances nanoparticle binding and delivery of a synthetic specialized pro-resolving lipid mediator to injured arteries.
    2023 | PubMed
  225. Effects of Diabetes on Elemental Levels and Nanostructure of Root Canal Dentin.
    2023 | PubMed
  226. Vascular health and the health of vascular surgery-2021 Western Vascular Society Presidential Address.
    2023 | PubMed
  227. Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia.
    2022 | PubMed
  228. Pedal arterial calcification score is associated with hemodynamic change and major amputation after infrainguinal revascularization for chronic limb-threatening ischemia.
    2022 | PubMed
  229. Applicability of the Vascular Quality Initiative mortality prediction model for infrainguinal revascularization in a tertiary limb preservation center population.
    2022 | PubMed
  230. A critical appraisal of registry-based objective performance goals in peripheral arterial disease.
    2021 | PubMed
  231. Closure device use for common femoral artery antegrade access is higher risk than retrograde access.
    2021 | PubMed
  232. Endovascular interventions for claudication do not meet minimum standards for the Society for Vascular Surgery efficacy guidelines.
    2020 | PubMed
  233. Editor's Choice - Relationship Between Global Limb Anatomic Staging System (GLASS) and Clinical Outcomes Following Revascularisation for Chronic Limb Threatening Ischaemia in the Bypass Versus Angioplasty in Severe Ischaemia of the Leg (BASIL)-1 Trial.
    2020 | PubMed
  234. Patient complexity by surgical specialty does not correlate with work relative value units.
    2020 | PubMed
  235. Appropriate use of revascularization for claudication.
    2020 | PubMed
  236. Building a Global Alliance in Vascular Surgery.
    2019 | PubMed
  237. Fish Oil Increases Specialized Pro-resolving Lipid Mediators in PAD (The OMEGA-PAD II Trial).
    2019 | PubMed
  238. Prognostic value of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification in patients with no-option chronic limb-threatening ischemia.
    2018 | PubMed
  239. Malignant ovarian germ cell tumors in pediatric patients: The AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica) study.
    2017 | PubMed
  240. Perivascular delivery of resolvin D1 inhibits neointimal hyperplasia in a rat model of arterial injury.
    2016 | PubMed
  241. Bypass surgery versus endovascular interventions in severe or critical limb ischemia.
    2015 | PubMed
  242. The vascular surgeon-scientist: a 15-year report of the Society for Vascular Surgery Foundation/National Heart, Lung, and Blood Institute-mentored Career Development Award Program.
    2015 | PubMed
  243. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service.
    2015 | PubMed
  244. Gender-specific risk factors for peripheral artery disease in a voluntary screening population.
    2014 | PubMed
  245. Vein graft failure.
    2013 | PubMed
  246. Critical appraisal of surgical revascularization for critical limb ischemia.
    2013 | PubMed
  247. Mitochondrial heat shock protein-90 modulates vascular smooth muscle cell survival and the vascular injury response in vivo.
    2012 | PubMed
  248. Chemical mediators of inflammation and resolution in post-operative abdominal aortic aneurysm patients.
    2012 | PubMed
  249. Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice.
    2011 | PubMed
  250. Shifting from open surgical cut down to ultrasound-guided percutaneous central venous catheterization in children: learning curve and related complications.
    2010 | PubMed
  251. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes?
    2009 | PubMed
  252. Suprarenal aortic cross-clamp position: a reappraisal of its effects on outcomes for open abdominal aortic aneurysm repair.
    2009 | PubMed
  253. Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia.
    2008 | PubMed
  254. Regulation of vascular smooth muscle cell growth by survivin.
    2007 | PubMed
  255. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery.
    2006 | PubMed
  256. Lower-extremity arterial disease.
    2005 | PubMed
  257. Infrainguinal vein bypass graft revision: factors affecting long-term outcome.
    2004 | PubMed
  258. Animal transmissible spongiform encephalopathies and genetics.
    2003 | PubMed
  259. Inhibitor of apoptosis protein survivin regulates vascular injury.
    2002 | PubMed
  260. Secondary aortoduodenal fistula.
    2001 | PubMed
  261. Minimally invasive video-assisted parathyroidectomy: lesson learned from 137 cases.
    2000 | PubMed
  262. Retroviral gene transfer: effects on endothelial cell phenotype.
    1998 | PubMed
  263. Endothelial cell seeding fails to attenuate intimal thickening in balloon-injured rabbit arteries.
    1995 | PubMed
  264. [Fluoroquinolones: pharmacokinetics and clinical use in pediatrics].
    1991 | PubMed
  265. Physicochemical Design of Nanoparticles to Interface with and Degrade Neutrophil Extracellular Traps.
    2025 | PubMed
  266. The Unique Device Identifier: A Unique Opportunity
    2023 | UCSF Research Profile
  267. Local versus global mechanical effects of intramural swelling in carotid arteries.
    2015 | PubMed
  268. Validation of the Society for Vascular Surgery Appropriate Use Criteria for management of intermittent claudication.
    2026 | PubMed
  269. Examination of Race and Ethnicity After Revascularization in the BEST-CLI Trial.
    2025 | PubMed
  270. Insulin therapy and outcomes of revascularization procedures for chronic limb-threatening ischemia in the BEST-CLI trial.
    2025 | PubMed
  271. Bypass Versus Endovascular Therapy for Elective Infrapopliteal Interventions in Chronic Limb-threatening Ischemia: Propensity Score-matched Analyses of Vascular Quality Initiative Registry.
    2025 | PubMed
  272. Engaging patients and their caregivers in research to improve evidence-based, patient-centered and equitable care for chronic limb-threatening ischemia and advanced peripheral artery disease.
    2025 | PubMed
  273. Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.
    2025 | PubMed
  274. Better limb staging in chronic limb-threatening ischemia: Why it matters.
    2024 | PubMed
  275. Surgery or endovascular therapy for patients with chronic limb-threatening ischemia requiring infrapopliteal interventions.
    2024 | PubMed
  276. Appropriateness of Care Measures: A Novel Approach to Quality.
    2024 | PubMed
  277. Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.
    2023 | PubMed
  278. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes and a foot ulcer.
    2023 | PubMed
  279. Baseline modern medical management in the BEST-CLI trial.
    2023 | PubMed
  280. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    2022 | PubMed
  281. Evaluation of the Global Limb Anatomic Staging System in patients with chronic limb-threatening ischemia undergoing endovascular intervention for femoropopliteal disease.
    2022 | PubMed
  282. Capturing the complexity of open abdominal aortic surgery in the endovascular era.
    2022 | PubMed
  283. A systematic review of patient-reported outcome measures patients with chronic limb-threatening ischemia.
    2022 | PubMed
  284. The Global Limb Anatomic Staging System (GLASS) for CLTI: Improving Inter-Observer Agreement.
    2021 | PubMed
  285. The Significance of the Global Vascular Guidelines for Podiatrists: Answers to Key Questions in the Diagnosis and Management of the Threatened Limb.
    2021 | PubMed
  286. A novel preoperative risk score for nonhome discharge after elective thoracic endovascular aortic repair.
    2020 | PubMed
  287. Comparison of the impact of ships to size-segregated particle concentrations in two harbour cities of northern Adriatic Sea.
    2020 | PubMed
  288. External validation of the Vascular Quality Initiative prediction model for survival in no-option chronic limb-threatening ischemia patients.
    2020 | PubMed
  289. Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular & Endovascular Surgery 58/1S (2019) 1-109].
    2019 | PubMed
  290. Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.
    2019 | PubMed
  291. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    2018 | PubMed
  292. Determinants of midterm functional outcomes, wound healing, and resources used in a hospital-based limb preservation program.
    2017 | PubMed
  293. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
    2016 | PubMed
  294. Critical Limb Ischemia: Current Trends and Future Directions.
    2016 | PubMed
  295. Risk Factors for 30-Day Hospital Readmission in Patients Undergoing Treatment for Peripheral Artery Disease.
    2015 | PubMed
  296. Evaluation and treatment of patients with lower extremity peripheral artery disease: consensus definitions from Peripheral Academic Research Consortium (PARC).
    2015 | PubMed
  297. Relationship between kidney disease and endothelial function in peripheral artery disease.
    2014 | PubMed
  298. Safety and feasibility of adjunctive dexamethasone infusion into the adventitia of the femoropopliteal artery following endovascular revascularization.
    2014 | PubMed
  299. Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.
    2013 | PubMed
  300. Effects of gravitational mechanical unloading in endothelial cells: association between caveolins, inflammation and adhesion molecules.
    2013 | PubMed
  301. Features of sensitization to airborne allergens among extra-European immigrants living in 2 distinct areas of Northern Italy.
    2012 | PubMed
  302. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells.
    2011 | PubMed
  303. Endothelial function predicts positive arterial-venous fistula remodeling in subjects with stage IV and V chronic kidney disease.
    2010 | PubMed
  304. Critical limb ischemia.
    2010 | PubMed
  305. In vivo differentiation of two vessel wall layers in lower extremity peripheral vein bypass grafts: application of high-resolution inner-volume black blood 3D FSE.
    2009 | PubMed
  306. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.
    2008 | PubMed
  307. Clinical results of carotid artery stenting compared with carotid endarterectomy.
    2008 | PubMed
  308. Restenosis after carotid endarterectomy performed with routine intraoperative duplex ultrasonography and arterial patch closure: a contemporary series.
    2007 | PubMed
  309. Retroperitoneoscopic lumbar sympathectomy for nonreconstructable arterial occlusive disease.
    2006 | PubMed
  310. Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein.
    2005 | PubMed
  311. Genetic therapy for vein bypass graft disease: current perspectives.
    2004 | PubMed
  312. Outcome in patients at high risk after open surgical repair of abdominal aortic aneurysm.
    2003 | PubMed
  313. Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.
    2002 | PubMed
  314. Minimally invasive video-assisted thyroidectomy.
    2001 | PubMed
  315. Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors.
    2000 | PubMed
  316. [Intensive chemotherapy with autologous stem cell transplantation in ovarian cancers: analysis of 67 patients treated at the Paoli-Calmettes Institute and a review of the literature].
    1997 | PubMed
  317. Efficient repopulation of denuded rabbit arteries with autologous genetically modified endothelial cells.
    1994 | PubMed
  318. Induction of ovulation by intermittent intravenous purified follicle-stimulating hormone in polycystic ovarian disease.
    1987 | PubMed
  319. A novel ergonomic simulator for laparoscopic surgery.
    2024 | PubMed
  320. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    2021 | PubMed
  321. Major Adverse Limb Events and Death After Successful Endovascular Revascularization: BEST-CLI Trial.
    2026 | PubMed
  322. The Diabetic Foot Consortium Biomarker Platform Study: A New Approach to Advance Diabetic Foot Ulcer Healing.
    2026 | PubMed
  323. Anatomically Directed Lower Extremity Gene Therapy for Ulcer Healing: A Double-Blind, Randomized, Placebo-Controlled Study (LEGenD-1).
    2025 | PubMed
  324. International BEST-CLI Collaborative: next steps to create a coordinated global initiative to improve awareness and access while reducing mortality and amputation for patients with chronic limb-threatening ischaemia.
    2025 | PubMed
  325. Antiproliferative endovascular drug technology is associated with fewer major reinterventions after femoropopliteal interventions for chronic limb-threatening ischemia.
    2025 | PubMed
  326. Impact of Bypass Conduit and Early Technical Failure on Revascularization for Chronic Limb-Threatening Ischemia.
    2025 | PubMed
  327. Low rates of aortic surveillance imaging and clinical follow-up in patients with acute aortic dissection.
    2024 | PubMed
  328. Prosthetic conduits have worse outcomes compared with great saphenous vein conduits in femoropopliteal and infrapopliteal bypass in patients with chronic limb-threatening ischemia.
    2024 | PubMed
  329. Endovascular therapy versus bypass for chronic limb-threatening ischemia in a real-world practice.
    2024 | PubMed
  330. Secondary interventions following open vs endovascular revascularization for chronic limb threatening ischemia in the BEST-CLI trial.
    2024 | PubMed
  331. Development and Validation of a Novel Preoperative Risk Score to Identify Patients at Risk for Nonhome Discharge after Elective Endovascular Aortic Aneurysm Repair (EVAR).
    2023 | PubMed
  332. Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: A systematic review.
    2023 | PubMed
  333. Patients with abdominal aortic aneurysms have reduced levels of microRNA 122-5p in circulating exosomes.
    2023 | PubMed
  334. Reply.
    2022 | PubMed
  335. Description and outcomes of patients with substance use disorder with serious bacterial infections who had a multidisciplinary care conference.
    2022 | PubMed
  336. Diabetes Mellitus Affects the Microhardness of Root Dentine: An in-vitro Study.
    2022 | PubMed
  337. Risk factors for venous thromboembolism after vascular surgery and implications for chemoprophylaxis strategies.
    2021 | PubMed
  338. Advances in Revascularization for Peripheral Artery Disease: Revascularization in PAD.
    2021 | PubMed
  339. Depression Predicts Non-Home Discharge After Abdominal Aortic Aneurysm Repair.
    2021 | PubMed
  340. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial.
    2020 | PubMed
  341. Increased Reintervention After Infrainguinal Revascularization for Chronic Limb-Threatening Ischemia in Women.
    2020 | PubMed
  342. Circulating exosomes from patients with peripheral artery disease influence vascular cell migration and contain distinct microRNA cargo.
    2020 | PubMed
  343. Risk score for nonhome discharge after lower extremity bypass.
    2019 | PubMed
  344. Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization.
    2019 | PubMed
  345. Interventions for lower extremity peripheral artery disease.
    2018 | PubMed
  346. Relationship between the omega-3 index and specialized pro-resolving lipid mediators in patients with peripheral arterial disease taking fish oil supplements.
    2017 | PubMed
  347. Unidirectional and sustained delivery of the proresolving lipid mediator resolvin D1 from a biodegradable thin film device.
    2016 | PubMed
  348. Nonrevascularization-based treatments in patients with severe or critical limb ischemia.
    2015 | PubMed
  349. Functional outcomes after lower extremity revascularization in nursing home residents: a national cohort study.
    2015 | PubMed
  350. Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction.
    2015 | PubMed
  351. Regarding "Presentation, treatment, and outcome differences between men and women undergoing revascularization or amputation for lower extremity peripheral arterial disease".
    2014 | PubMed
  352. Adventitial nab-rapamycin injection reduces porcine femoral artery luminal stenosis induced by balloon angioplasty via inhibition of medial proliferation and adventitial inflammation.
    2013 | PubMed
  353. D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury.
    2013 | PubMed
  354. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.
    2012 | PubMed
  355. An integrated biochemical prediction model of all-cause mortality in patients undergoing lower extremity bypass surgery for advanced peripheral artery disease.
    2012 | PubMed
  356. Mineralocorticoid receptor expression in human venous smooth muscle cells: a potential role for aldosterone signaling in vein graft arterialization.
    2011 | PubMed
  357. Understanding objective performance goals for critical limb ischemia trials.
    2010 | PubMed
  358. Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.
    2009 | PubMed
  359. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia.
    2009 | PubMed
  360. C-reactive protein and vein graft disease: evidence for a direct effect on smooth muscle cell phenotype via modulation of PDGF receptor-beta.
    2008 | PubMed
  361. Female gender and oral anticoagulants are associated with wound complications in lower extremity vein bypass: an analysis of 1404 operations for critical limb ischemia.
    2007 | PubMed
  362. Refinement of survival prediction in patients undergoing lower extremity bypass surgery: stratification by chronic kidney disease classification.
    2007 | PubMed
  363. Survivin regulation of vascular injury.
    2006 | PubMed
  364. Gene therapy for the extension of vein graft patency: a review.
    2005 | PubMed
  365. Early adaptation of human lower extremity vein grafts: wall stiffness changes accompany geometric remodeling.
    2004 | PubMed
  366. Genetic interventions for vein bypass graft disease: a review.
    2002 | PubMed
  367. Impact of harmonic scalpel on operative time during video-assisted thyroidectomy.
    2001 | PubMed
  368. Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective.
    2001 | PubMed
  369. Improved graft patency and altered remodeling in infrainguinal vein graft reconstruction for aneurysmal versus occlusive disease.
    1999 | PubMed
  370. Femorotibial bypass for claudication: do results justify an aggressive approach?
    1995 | PubMed
  371. Percutaneous ultrasound-guided drainage of intra-abdominal abscesses.
    1993 | PubMed
  372. Development and validation of an ultra-low-cost, open source normothermic ex vivo organ perfusion platform.
    2025 | PubMed
  373. GPT-4: A Creative Copilot for Navigating Academic Surgery.
    2023 | PubMed
  374. Antegrade common femoral artery closure device use is associated with decreased complications.
    2020 | PubMed
  375. Discoloration, radiopacity, and push-out bond strength of bismuth-based radiopacifiers in endodontic sealers.
    2026 | PubMed
  376. Contemporary outcomes of lower extremity vein bypass for chronic limb-threatening ischemia based on a post hoc comparison of the BEST-CLI and PREVENT III multicenter prospective randomized controlled trials.
    2025 | PubMed
  377. Cost-effectiveness of endovascular versus open surgery for chronic limb-threatening ischemia.
    2025 | PubMed
  378. Percutaneous Deep Venous Arterialization for Advanced Limb Ischemia.
    2025 | PubMed
  379. Redefining reference intervals for baseline serum tryptase: found the solution?
    2025 | PubMed
  380. Outcomes for Hispanic patients undergoing open bypass in BEST-CLI.
    2025 | PubMed
  381. Impact of skin closure with staples vs sutures on perioperative outcomes following lower extremity bypass surgery.
    2024 | PubMed
  382. Early Opioid Use and Postoperative Delirium Following Open Abdominal Aortic Aneurysm Repair.
    2024 | PubMed
  383. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial.
    2024 | PubMed
  384. BEST-CLI International Collaborative: planning a better future for patients with chronic limb-threatening ischaemia globally.
    2024 | PubMed
  385. Editor's Choice - The Intersocietal IWGDF, ESVS, SVS Guidelines on Peripheral Artery Disease in People With Diabetes Mellitus and a Foot Ulcer.
    2023 | PubMed
  386. Perioperative complications following open or endovascular revascularization for chronic limb-threatening ischemia in the BEST-CLI Trial.
    2023 | PubMed
  387. Structured discharge documentation reduces sex-based disparities in statin prescription in vascular surgery patients.
    2023 | PubMed
  388. Racial and ethnic disparities in major adverse limb events persist for chronic limb threatening ischemia despite presenting limb threat severity after peripheral vascular intervention.
    2022 | PubMed
  389. Clinical Predictors and Outcomes Associated with Postoperative Delirium Following Infrainguinal Bypass Surgery.
    2022 | PubMed
  390. Analysis of a Machine Learning-Based Risk Stratification Scheme for Chronic Limb-Threatening Ischemia.
    2022 | PubMed
  391. Feasibility of Photo-Optical Transcutaneous Oxygen Tension Measurement During Revascularization of the Lower Extremity.
    2021 | PubMed
  392. Contemporary Experience with Paravisceral Aortic Aneurysm (PVAAA) Repair in a Tertiary Center.
    2021 | PubMed
  393. SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy.
    2020 | PubMed
  394. Treatment With a Marine Oil Supplement Alters Lipid Mediators and Leukocyte Phenotype in Healthy Patients and Those With Peripheral Artery Disease.
    2020 | PubMed
  395. Meaningful change in 6-minute walk in people with peripheral artery disease.
    2020 | PubMed
  396. Reply.
    2020 | PubMed
  397. Critical review and evidence implications of paclitaxel drug-eluting balloons and stents in peripheral artery disease.
    2019 | PubMed
  398. Invited commentary.
    2018 | PubMed
  399. Effect of a Home-Based Exercise Intervention of Wearable Technology and Telephone Coaching on Walking Performance in Peripheral Artery Disease: The HONOR Randomized Clinical Trial.
    2018 | PubMed
  400. Biosynthesis of proresolving lipid mediators by vascular cells and tissues.
    2017 | PubMed
  401. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    2016 | PubMed
  402. Short-Term, High-Dose Fish Oil Supplementation Increases the Production of Omega-3 Fatty Acid-Derived Mediators in Patients With Peripheral Artery Disease (the OMEGA-PAD I Trial).
    2015 | PubMed
  403. Systemic delivery of proresolving lipid mediators resolvin D2 and maresin 1 attenuates intimal hyperplasia in mice.
    2015 | PubMed
  404. Advancing beyond the "heart-healthy diet" for peripheral arterial disease.
    2015 | PubMed
  405. Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.
    2014 | PubMed
  406. n-3 Polyunsaturated fatty acids supplementation in peripheral artery disease: the OMEGA-PAD trial.
    2013 | PubMed
  407. Setting high-impact clinical research priorities for the Society for Vascular Surgery.
    2013 | PubMed
  408. Clinical practice. Acute limb ischemia.
    2012 | PubMed
  409. Efficacy of optimal long-term management of multiple cardiovascular risk factors (CVD) on walking and quality of life in patients with peripheral artery disease (PAD): protocol for randomized controlled trial.
    2012 | PubMed
  410. Discussion. Open surgical revascularization for wound healing: past performance and future directions; and Critical evaluation of endovascular surgery for limb salvage.
    2011 | PubMed
  411. Aspirin prophylaxis (100 mg daily) does not improve cardiovascular outcomes compared to placebo in asymptomatic individuals with incidental low-ankle brachial index.
    2010 | PubMed
  412. Premarket assessment of devices for treatment of critical limb ischemia: the role of Objective Performance Criteria and Goals.
    2009 | PubMed
  413. Disparity in outcomes of surgical revascularization for limb salvage: race and gender are synergistic determinants of vein graft failure and limb loss.
    2008 | PubMed
  414. High-resolution peripheral vein bypass graft wall studies using high sampling efficiency inner volume 3D FSE.
    2008 | PubMed
  415. Surgical and endovascular revision of infrainguinal vein bypass grafts: analysis of midterm outcomes from the PREVENT III trial.
    2007 | PubMed
  416. Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia.
    2006 | PubMed
  417. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage.
    2005 | PubMed
  418. Matrix metalloproteinase-specific inhibition of Ca2+ entry mechanisms of vascular contraction.
    2004 | PubMed
  419. Preoperative risk factors for carotid endarterectomy: defining the patient at high risk.
    2003 | PubMed
  420. Bypass in the absence of ipsilateral greater saphenous vein: safety and superiority of the contralateral greater saphenous vein.
    2002 | PubMed
  421. Targeting platelet aggregation: CD39 gene transfer augments nucleoside triphosphate diphosphohydrolase activity in injured rabbit arteries.
    2001 | PubMed
  422. [Phyllodes tumor of the breast. Personal contribution of 21 cases].
    2000 | PubMed
  423. Antiplatelet therapy and patency of saphenous-vein bypass grafts in the legs.
    1998 | PubMed
  424. Preferred strategies for secondary infrainguinal bypass: lessons learned from 300 consecutive reoperations.
    1995 | PubMed
  425. Delayed exposure to pulsatile shear stress improves retention of human saphenous vein endothelial cells on seeded ePTFE grafts.
    1991 | PubMed
  426. An Analysis of Political Contributions by the American College of Surgeons Professional Association (SurgeonsPAC).
    2024 | PubMed
  427. Open revascularization approach is associated with healing and ambulation after transmetatarsal amputation in patients with chronic limb threatening ischemia.
    2022 | PubMed